Use of quinolines and quinolones to treat male erectile dysfunct

Details Use of quinolines and quinolones to treat male erectile dysfunct Use of quinolines and quinolones to treat male erectile dysfunct

1998-05-01

2000-08-29

Azpuru, Carlos A.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424 7807, 424430, 424443, 424DIG15, 128844, A61F 1302, A61F 606, A61F 604, A61K 3174

Patent

active

061104892

ABSTRACT:
Methods for treating male erectile dysfunction are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions to induce erections in males with male erectile dysfunction. The pharmaceutical compositions comprise quinolines and quinolones, as well as derivatives thereof.

REFERENCES:
patent: 1897423 (1933-02-01), Ferri
patent: 2584166 (1952-02-01), Stevenson et al.
patent: 2696209 (1954-12-01), Varaney
patent: 3373746 (1968-03-01), White
patent: 4311707 (1982-01-01), Birnbaum et al.
patent: 4478822 (1984-10-01), Haslam et al.
patent: 4610868 (1986-09-01), Fountain et al.
patent: 4640912 (1987-02-01), Hausman
patent: 4746508 (1988-05-01), Carey et al.
patent: 4801587 (1989-01-01), Voss
patent: 4829991 (1989-05-01), Boeck
patent: 5011931 (1991-04-01), MacLean et al.
patent: 5079264 (1992-01-01), MacLean et al.
patent: 5270323 (1993-12-01), Milne, Jr. et al.
patent: 5447912 (1995-09-01), Gerstenberg et al.
patent: 5474535 (1995-12-01), Place et al.
patent: 5492911 (1996-02-01), Stief
patent: 5721238 (1998-02-01), Heiker
patent: 5773457 (1998-06-01), Nahoum
Dawson et al., "Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial," Circulation, 98(7):678-86 (1998).
Minami et al., "Inhibition of Shear Stree-Induced Platelet Aggregattion By Cilostazol, A Specific Inhibitor of cGMP-Inhibited Phosphodiesterase, In Vitro and Ex Vivo," Life Sciences, 61(25):PL 383-389 (1997).
Shiraishi et al., "Effect of cilostazol, a phosphodiesterase type III inhibitor, On Histamine-induced increase in [Ca2+]i and force in middle cerebral artery of the rabbit," Br. J. Pharmacol., 123(5):869-878 (1997).
McMurry, Organic Chemistry, 2nd Ed., Brooks/Cole Publishing, Belmont, CA (1988), pp. 1044-1045 and 1076.
Kelso, et al., "Actions of the Novel Vasodilator, Flosequinan, in Isolated Ventricular Cardiomyocytes," J. Cardiovasc. Pharmacol. 25:376-386 (1995).
Perreault, et al., "Differential intropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure," Br. J. Pharmacol. 106:511-516 (1992).
Jones, et al., "Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat," Br. J. Pharmacol. 108:1111-1116 (1993).
Gristwood, et al., "Studies on the cardiac actions of flosequinan in vitro," Br. J. Pharmacol. 105:985-991 (1992).
Frodsham, et al., "Effect of flosequinan upon isoenzymes of phosphodiesterase from guinea-pig cardiac and vascular smooth muscle," Eur. J. Pharmacol. 211:383-391 (1992).
Delcour et al., "Impotence: Evaluation with Cavernosography," Radiology 161:803-806(1986).
Porst et al., "Relevance of Dynamic Cavernosography to the Diagnosis of Venous Incompetance in Erectile Dysfunction," J. Urol. 137:1163-1167 (1987).
Lue et al., "Physiology of Erection and Pharmacological Management of Impotence," J. Urol. 37:829-836 (1987).
Garban et al., "Effect of aging on nitric oxide-mediated penile erection in rats," Am. J. Phys. 46:H467-H475 (1995).
Rajfer et al., "Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission," New Engl. J. Med. 326:90-94 (1992).
Boolel et al., "Sildenafil, a novel effective oral therapy for male erectile dysfunction," Br. J. Ur. 78:257-261 (1996).
Silver et al., "Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle," European J. Pharmacology, 150:85-94 (1988).
Kauffmann et al., "Characterization and Pharmacological Relevance of High Affinity Binding Sites for [.sup.3 H]LY186126, a Cardiotonic Phosphodiesterase Inhibitors, in Canine Cardiac Membranes," Circulation Research, 65(1):154-163.
Park et al., "Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clotoral erectile insufficiency," Int. J. Impotence Res., 9:27-37 (1997).
Malhotra et al., "Cavernosography in Conjuction with Artificial Erection for Evaluation of Venous Leakage in Impotent Men," Radiology, 161:799-802 (1986).

Affiliated with

Also associated with

Rating

Use of quinolines and quinolones to treat male erectile dysfunct does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of quinolines and quinolones to treat male erectile dysfunct, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of quinolines and quinolones to treat male erectile dysfunct will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1246908